Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ly-Mee Yu

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
The Lancet. Psychiatry|February 9, 2024
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trialCathy Creswell, Lucy Taylor, Sophie Giles, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccineTeresa Lambe, Alexandra J Spencer, Caitlin E Mullarkey, et al.
The Lancet. Infectious Diseases|January 13, 2019
Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trialRama Kandasamy, Meeru Gurung, Stephen Thorson, et al.
The Lancet. Microbe|April 26, 2026
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC)David M Lowe, Shengyuan Zhang, Samuel Ellis, et al.
BMJ (Clinical Research Ed.)|February 8, 2022
Early phase clinical trials extension to guidelines for the content of statistical analysis plansVictoria Homer, Christina Yap, Simon Bond, et al.
The Pediatric Infectious Disease Journal|January 26, 2013
Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infantsAmeneh Khatami, Matthew D Snape, Brigitte Ohene-Kena, et al.
NPJ Vaccines|July 13, 2023
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in childrenDmitri Kazmin, Elizabeth A Clutterbuck, Giorgio Napolitani, et al.
Vaccines|August 28, 2021
Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS)Chris Butler, Chris Ellis, Pedro M Folegatti, et al.
Lancet (London, England)|August 13, 2023
Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trialSimon D Kyle, A Niroshan Siriwardena, Colin A Espie, et al.
Schizophrenia Research|November 7, 2022
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trialDaniel Freeman, Sinéad Lambe, Ushma Galal, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
The Lancet. Psychiatry|February 9, 2024
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trialCathy Creswell, Lucy Taylor, Sophie Giles, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccineTeresa Lambe, Alexandra J Spencer, Caitlin E Mullarkey, et al.
The Lancet. Infectious Diseases|January 13, 2019
Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trialRama Kandasamy, Meeru Gurung, Stephen Thorson, et al.
The Lancet. Microbe|April 26, 2026
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC)David M Lowe, Shengyuan Zhang, Samuel Ellis, et al.
BMJ (Clinical Research Ed.)|February 8, 2022
Early phase clinical trials extension to guidelines for the content of statistical analysis plansVictoria Homer, Christina Yap, Simon Bond, et al.
The Pediatric Infectious Disease Journal|January 26, 2013
Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infantsAmeneh Khatami, Matthew D Snape, Brigitte Ohene-Kena, et al.
NPJ Vaccines|July 13, 2023
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in childrenDmitri Kazmin, Elizabeth A Clutterbuck, Giorgio Napolitani, et al.
Vaccines|August 28, 2021
Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS)Chris Butler, Chris Ellis, Pedro M Folegatti, et al.
Lancet (London, England)|August 13, 2023
Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trialSimon D Kyle, A Niroshan Siriwardena, Colin A Espie, et al.
Schizophrenia Research|November 7, 2022
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trialDaniel Freeman, Sinéad Lambe, Ushma Galal, et al.
Pageof 19